Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27223 | 192 | 29.4 | 64% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | REMACEMIDE | Author keyword | 49 | 78% | 17% | 32 |
| 2 | LOSIGAMONE | Author keyword | 23 | 74% | 9% | 17 |
| 3 | REMACEMIDE HYDROCHLORIDE | Author keyword | 9 | 64% | 5% | 9 |
| 4 | COLOR AND POSITION DISCRIMINATION | Author keyword | 9 | 67% | 4% | 8 |
| 5 | TEMPORAL RESPONSE DIFFERENTIATION | Author keyword | 8 | 70% | 4% | 7 |
| 6 | INCREMENTAL REPEATED ACQUISITION | Author keyword | 8 | 60% | 5% | 9 |
| 7 | DESGLYCINYL REMACEMIDE | Author keyword | 6 | 100% | 2% | 4 |
| 8 | RESPONSE DURATION DIFFERENTIATION | Author keyword | 4 | 75% | 2% | 3 |
| 9 | OPERANT TEST BATTERY | Author keyword | 2 | 67% | 1% | 2 |
| 10 | FAST SODIUM CHANNELS | Author keyword | 2 | 50% | 2% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTICONVULSANT REMACEMIDE | 34 | 79% | 11% | 22 |
| 2 | DESGLYCINYL METABOLITE | 6 | 71% | 3% | 5 |
| 3 | BEHAVIORAL TEST BATTERY | 6 | 53% | 4% | 8 |
| 4 | ARL 15896AR | 6 | 100% | 2% | 4 |
| 5 | REMACEMIDE HYDROCHLORIDE | 5 | 40% | 5% | 10 |
| 6 | PRECLINICAL PROFILE | 4 | 25% | 8% | 15 |
| 7 | DOSE LEVELS 300 | 4 | 75% | 2% | 3 |
| 8 | TETRONIC ACID DERIVATIVES | 3 | 42% | 3% | 5 |
| 9 | MARIJUANA SMOKE | 2 | 26% | 4% | 8 |
| 10 | MUTUAL INTERACTION | 2 | 24% | 4% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Remacemide hydrochloride: A novel antiepileptic agent | 1997 | 26 | 21 | 48% |
| Remacemide - A novel potential antiepileptic drug | 2003 | 7 | 55 | 56% |
| Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies | 2001 | 91 | 170 | 11% |
| REPEATED ACQUISITION OF RESPONSE SEQUENCES - THE ANALYSIS OF BEHAVIOR IN TRANSITION | 1995 | 19 | 21 | 48% |
| Losigamone add-on therapy for partial epilepsy | 2012 | 0 | 19 | 42% |
| Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions | 2009 | 63 | 150 | 16% |
| Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs - an update | 2005 | 15 | 78 | 14% |
| Perspectives of losigamone in epilepsy treatment | 2003 | 2 | 41 | 32% |
| The treatment of epilepsy: Future possibilities | 2003 | 8 | 116 | 11% |
| Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: From review to preview | 2015 | 2 | 73 | 5% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IST SCI NEUROL NEUROCHIRURG | 2 | 50% | 1.6% | 3 |
| 2 | BEHAV TOXICOL | 1 | 38% | 1.6% | 3 |
| 3 | BEHAV TOXICOL S | 1 | 50% | 0.5% | 1 |
| 4 | MINCEP | 0 | 33% | 0.5% | 1 |
| 5 | IST SCI BIOCHIM BIOCHIM CLIN | 0 | 25% | 0.5% | 1 |
| 6 | SINO GERMAN EPILEPSY | 0 | 20% | 0.5% | 1 |
| 7 | NANOTECHNOL DRUG | 0 | 13% | 0.5% | 1 |
| 8 | ACUTE STROKE UNITGARDINER | 0 | 100% | 0.5% | 1 |
| 9 | COMP BASED SYST INC | 0 | 100% | 0.5% | 1 |
| 10 | EPILEPSY THER EUT BRANCH | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000127293 | 1 AMINOCYCLOPROPANECARBOXYLIC ACID//ACEA 1021//7 CHLOROKYNURENIC ACID |
| 2 | 0.0000122759 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
| 3 | 0.0000120662 | EXPTL EPILEPSIEFOR//EXPERIMENTAL EPILEPSY MODELS//MODEL NERVOUS SYSTEM |
| 4 | 0.0000114461 | PHENCYCLIDINE//METAPHIT//CAS 956 90 1 |
| 5 | 0.0000114399 | LACOSAMIDE//ESLICARBAZEPINE ACETATE//PERAMPANEL |
| 6 | 0.0000101304 | DRL BEHAVIOR//DRL 72 S SCHEDULE//BEHAVIORAL SCREEN |
| 7 | 0.0000098871 | ANTICONVULSANT ACTIVITY//MES TEST//EPILEPSY BRANCH |
| 8 | 0.0000090646 | GUINEA PIG BLADDER//NK2 TACHYKININ RECEPTOR//ACETYCHOLINE RELEASE |
| 9 | 0.0000083838 | DELAYED MATCHING TO SAMPLE//DIFFERENTIAL OUTCOMES EFFECT//FORGETTING FUNCTIONS |
| 10 | 0.0000083574 | CLOMETHIAZOLE//CHLORMETHIAZOLE//CHLOMETHIAZOLE |